Product NDC: | 53808-0758 |
Proprietary Name: | Pentoxifylline |
Non Proprietary Name: | Pentoxifylline |
Active Ingredient(s): | 400 mg/1 & nbsp; Pentoxifylline |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 53808-0758 |
Labeler Name: | State of Florida DOH Central Pharmacy |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA074425 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090701 |
Package NDC: | 53808-0758-1 |
Package Description: | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (53808-0758-1) |
NDC Code | 53808-0758-1 |
Proprietary Name | Pentoxifylline |
Package Description | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (53808-0758-1) |
Product NDC | 53808-0758 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Pentoxifylline |
Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20090701 |
Marketing Category Name | ANDA |
Labeler Name | State of Florida DOH Central Pharmacy |
Substance Name | PENTOXIFYLLINE |
Strength Number | 400 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Blood Viscosity Reducer [EPC],Hematologic Activity Alteration [PE] |